Citadel Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.89M | Sell |
|
|||||
|
2025
Q2 | $15.9M | Buy |
|
|||||
|
2025
Q1 | $5.72M | Buy |
|
|||||
|
2024
Q4 | $1.61M | Buy |
|
|||||
|
2024
Q3 | $813 | Sell |
|
|||||
|
2024
Q2 | $8.85M | Buy |
|
|||||
|
2024
Q1 | $6.07M | Sell |
|
|||||
|
2023
Q4 | $10.1M | Buy |
|
|||||
|
2023
Q3 | $10.8M | Buy |
|
|||||
|
2023
Q2 | $22.9M | Buy |
|
|||||
|
2023
Q1 | $1.41M | Buy |
|
|||||
|
2022
Q4 | $140K | Sell |
|
|||||
|
2022
Q3 | $4.84M | Sell |
|
|||||
|
2022
Q2 | $28.9M | Buy |
|
|||||
|
2022
Q1 | $28.8M | Buy |
|
|||||
|
2021
Q4 | $9.55M | Sell |
|
|||||
|
2021
Q3 | $15.3M | Buy |
|
|||||
|
2021
Q2 | $24.7M | Buy |
|
|||||
|
2021
Q1 | $13.5M | Buy |
|
|||||
|
2020
Q4 | $12.1M | Sell |
|
|||||
|
2020
Q3 | $23.3M | Buy |
|
|||||
|
2020
Q2 | $6.77M | Buy |
|
|||||
|
2020
Q1 | $7.07M | Buy |
|
|||||
|
2019
Q4 | $8.42M | Buy |
|
|||||
|
2019
Q3 | $1.65M | Sell |
|
|||||
|
2019
Q2 | $2.15M | Sell |
|
|||||
|
2019
Q1 | $3.38M | Sell |
|
|||||
|
2018
Q4 | $8.72M | Buy |
|
|||||
|
2018
Q3 | $3.21M | Sell |
|
|||||
|
2018
Q2 | $21.1M | Sell |
|
|||||
|
2018
Q1 | $26M | Buy |
|
|||||
|
2017
Q4 | $8.97M | Buy |
|
|||||
|
2017
Q3 | $3.4M | Buy |
|
|||||
|
2017
Q2 | $955K | Buy |
|
|||||
|
2017
Q1 | $92K | Sell |
|
|||||
|
2016
Q4 | $131K | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $261K | Buy |
|